» Articles » PMID: 34681566

Exosome Degeneration in Mesenchymal Stem Cells Derived from Patients with Type 1 Diabetes Mellitus

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Oct 23
PMID 34681566
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Type 1 diabetes mellitus is characterized by the destruction of pancreatic β-cells and requires the regeneration of these destroyed pancreatic β-cells for radical treatment. The degeneration of organelles in stem cells compromises stem cell quality; however, organelles in the mesenchymal stem cells of patients with type 1 diabetes mellitus have not been characterized previously. In this study, we use transmission electron microscopy to evaluate the degeneration of organelles in adipose-derived stem cells of patients with type 1 diabetes mellitus (T1DM ADSCs). Compared to adipose-derived stem cells from healthy humans, T1DM ADSCs degenerate differently, characterized by prominent enlarged spherical vesicles. The exosomes of T1DM ADSCs are found to be enlarged, reduced in number, and increased in the percentage of those positive for tetraspanin CD9. The findings of this study provide insight into the characteristics of stem cells in patients with type 1 diabetes mellitus.

Citing Articles

The Diurnal Variation in Mitochondrial Gene in Human Type 2 Diabetic Mesenchymal Stem Cell Grafts.

Horiguchi M, Yoshihara K, Mizukami Y, Watanabe K, Tsurudome Y, Ushijima K Int J Mol Sci. 2025; 26(2.

PMID: 39859433 PMC: 11765740. DOI: 10.3390/ijms26020719.


Exosomes in Autoimmune Diseases: A Review of Mechanisms and Diagnostic Applications.

Duan L, Lin W, Zhang Y, Jin L, Xiao J, Wang H Clin Rev Allergy Immunol. 2025; 68(1):5.

PMID: 39820756 DOI: 10.1007/s12016-024-09013-2.


Circadian Rhythms of Clock Genes After Transplantation of Mesenchymal Stem Cells with Type 2 Diabetes Mellitus.

Horiguchi M, Yoshihara K, Watanabe K, Tsurudome Y, Mizukami Y, Ushijima K Int J Mol Sci. 2024; 25(23).

PMID: 39684854 PMC: 11641841. DOI: 10.3390/ijms252313145.


Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency.

Zhang R, Mu X, Liu D, Chen C, Meng B, Qu Y J Nanobiotechnology. 2024; 22(1):580.

PMID: 39304875 PMC: 11414301. DOI: 10.1186/s12951-024-02829-2.


Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency.

Zhang R, Mu X, Liu D, Chen C, Meng B, Qu Y Res Sq. 2024; .

PMID: 38883762 PMC: 11177995. DOI: 10.21203/rs.3.rs-4416138/v1.


References
1.
Kondo Y, Toyoda T, Inagaki N, Osafune K . iPSC technology-based regenerative therapy for diabetes. J Diabetes Investig. 2017; 9(2):234-243. PMC: 5835458. DOI: 10.1111/jdi.12702. View

2.
Chhabra P, Brayman K . Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med. 2013; 2(5):328-36. PMC: 3667565. DOI: 10.5966/sctm.2012-0116. View

3.
Tkach M, Thery C . Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell. 2016; 164(6):1226-1232. DOI: 10.1016/j.cell.2016.01.043. View

4.
Horiguchi M, Hata S, Tsurudome Y, Ushijima K . Characterizing the degeneration of nuclear membrane and mitochondria of adipose-derived mesenchymal stem cells from patients with type II diabetes. J Cell Mol Med. 2021; 25(9):4298-4306. PMC: 8093988. DOI: 10.1111/jcmm.16484. View

5.
van Niel G, DAngelo G, Raposo G . Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19(4):213-228. DOI: 10.1038/nrm.2017.125. View